Structural heart devices Market are medical devices with the ability to pump blood by way of the heart. This device is called the ventricular myocardium, and it is what pumps blood from the heart to the various chambers of the body. The structure that this type of heart device has is very basic - a couple of stacks of cells (or more, depending upon the desired function), and a tubing filled with fluid that can allow for the movement of the cells. This particular construction has allowed these devices to be built so that they can pump blood and create heart attacks and heart failure with much greater efficiency.
Lack of skilled personnel
and low affordability is expected to restrain growth of the global structural
heart devices market during the forecast period. However, the emergence of
tissue-engineered heart valves and the advent of percutaneous interventions can
offer major business opportunities in the global structural heart devicesmarket.
Key players involved in
the global structural heart devices market are Boston Scientific Corporation,
CardioKinetix, Medtronic, JenaValve Technology, Inc., Edwards Lifesciences
Corporation, LivaNova plc, Abbott Laboratories, Comed BV, ST. Jude Medical, and
Biomerics.
For instance, in October
2020, Medtronic, a major medical technology company, partnered with The
Foundry, a medical device company, to develop innovative Mitral Valve Repair
Technology.
Comments
Post a Comment